-+ 0.00%
-+ 0.00%
-+ 0.00%

RONA THERAPEUTICS ENTERS INTO GLOBAL LICENSE AGREEMENT WITH ROCHE FOR ALK7-TARGETING RNAI THERAPY FOR OBESITY AND METABOLIC DISEASES

Reuters·10/13/2026 07:00:01

Please log in to view news